Tuesday's #PreMarket Movers: Neuroderm, Microsoft, Medbox, Civeo And More

Neuroderm Ltd NDRM +30% - The company announced favorable Phase IIa Parkinson’s treatment study results.

China Jo-Jo Drugstores Inc CJJD +9% - Shares are higher following a report of potential legalization of online prescription drugs sales in China.

XenoPort, Inc. XNPT +9% - Late Monday, RBC analyst Michael Yee said XenoPort is his “under the radar play for 2015.”

Kandi Technologies Group Inc KNDI +4.3% - The rise in share price is a result of the announcement that China will extend green vehicle subsidies until 2020.

Cnova NV CNV +3% - Shares were initiated with an Overweight rating at JPMorgan and Morgan Stanleyand a Buy rating at Bank of America.

Idera Pharmaceuticals Inc IDRA +1.8% - The company received FDA orphan drug designation for IMO-8400.

Ariad Pharmaceuticals, Inc. ARIA +1% - Ariad announced a commercialization deal for Iclusig in seven countries.

Microsoft Corporation MSFT +0.11% - Microsoft named “top pick” at Piper Jaffray for 2015.

Civeo Corp CVEO -35% - After hours Monday, the company announced Q1 guidance below estimates and suspended its quarterly dividend.

Medbox Inc MDBX -16% - The company announced it will amend prior period financial results.

Procter & Gamble Co PG -1% - Shares were downgraded to Neutral at BTIG.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMoversBank of AmericaJP MorganMichael YeeMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!